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When Charles Darwin’s daughter Anne Elizabeth
(‘Annie’, Photograph 1) died at the age of 10 years
on April 23, 1851 her parents were devastated.
Charles Darwin was a devoted father and constantly
concerned about the health of his 10 children. His
concerns were also motivated by fear of the conse-
quences of marriage between relatives: Emma
Wedgewood, his wife, was also his first cousin.1 The
possible adverse effects of consanguineous marriage,
which was not uncommon in England at that time,
were a matter of debate. Annie’s death, and
self-fertilization experiments in plants, made him
suspect that ‘marriage between near relations is like-
wise injurious’.2 In 1870, Darwin motivated his
mathematician son George to study the prevalence
of close-kin marriages in patients in asylums in com-
parison with the prevalence of the general population.
The study, which is reprinted in this issue of the
journal,3 with several commentaries,1,2,4,5 was first
published in 1875 and concluded that ‘the evil [of
marriages between cousins] has been often much
exaggerated’ and that ‘under favourable conditions
of life, the apparent ill-effects were frequently
almost nil’.3
Indeed, Annie died after a lingering illness, most
likely of tuberculosis (TB) caused by Mycobacterium
tuberculosis,6 and not of the consequences of a high
coefficient of inbreeding (the F coefficient that
features in one commentary2). Of note, although
Darwin may have been aware of the studies by his
contemporaries, Pasteur and Koch, he did not con-
sider the role of microbes and infectious diseases in
his work.7 M. tuberculosis would, however, surely have
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been of interest. This obligate human pathogen has
co-evolved with humans for millennia8 and has
been extremely successful: today one-third of the
world’s population is estimated to be infected and
1.7 million people die from TB each year, more
than anytime during previous human history.9,10
Co-infection with HIV is an important risk factor for
TB, increasing the lifetime risk of progression from
infection to active disease from 5% per lifetime to
5% per year,11 which is a particular problem in
sub-Saharan Africa. Moreover, the emergence of bac-
terial strains resistant to most current antimicrobial
drugs threatens to make TB untreatable.9 Edmonds
and colleagues,12 in this issue, document the stagger-
ingly high incidence of TB in HIV-infected children in
Kinshasa, Democratic Republic of Congo: 20.4 per
100 person-years. Anti-retroviral therapy halved the
incidence of TB, but as Boulle and Eley emphasize
in their commentary,13 additional interventions are
needed to control TB in this population, including
efforts to improve the diagnosis of TB in children
co-infected with HIV.
Darwin would of course understand: the theory of
evolution which he outlined in his seminal work
On the Origin of Species by Means of Natural Selection, or
the Preservation of Favoured Races in the Struggle for Life is
also ‘the modern story of TB’.14 The recent emergence
of HIV and the introduction of effective drugs
represent selection pressures that M. tuberculosis has
not experienced for most of its evolutionary history.
As one consequence of the widespread (and not
always well supervised) use of drugs, resistant strains
have developed. Many drug resistance-conferring
mutations in M. tuberculosis lead to a reduction in
bacterial fitness, although compensatory evolution
may mitigate fitness defects.15 In HIV-infected,
immune-compromised hosts even strains with
high-cost resistance mutations could be propagating
efficiently, which might explain why drug-resistant
TB has been associated with HIV co-infection.16,17
TB patients could thus serve as a ‘breeding ground’
for highly compensated drug-resistant strains, with an
increased capacity to spread in the general population.
To date, no study has addressed this disturbing
possibility. The strain genetic background has also
been shown to influence the fitness of drug-resistant
M. tuberculosis. For example, the Beijing lineage has
been associated with drug resistance,18 suggesting
that this lineage might be ‘pre-adapted’ to resistance.
Importantly, Beijing has also been associated with
HIV19,20 and is now emerging in South Africa,
probably as a consequence of the HIV epidemic.21,22
Genomics, the study of the genomes of organisms, is
becoming increasingly important for communicable
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Figure 1 A ‘systems epidemiology’ approach to tuberculosis, which integrates demography, ecology and systems biology.
Picture credits: Drawing from Koch R. Die Aetiologie der Tuberkulose. Berliner Klinische Wochenschrift, 1882; Dens of
Death. Photograph from Riis JA. The Battle with the Slum. New York: MacMillan Company, 1902; Drawing of man with
tuberculosis (source unknown).
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disease epidemiology and control. Infectious diseases
result from complex interactions between microbes,
host and the environment, which are subject to evo-
lutionary pressures and ecological changes (Figure 1).
Genetic and immunological studies can answer fun-
damental questions about host–pathogen interaction,
pathogenesis, host genetic susceptibility and the
factors influencing response to treatment and progno-
sis.23 Humans show remarkable variation in their
response to infectious agents. For example, particular
human gene polymorphisms explain some of the vari-
ation among individuals who differ in their ability to
control HIV infection.24,25 In addition to host genetic
diversity, genetic variation within particular microbial
species can influence the outcome of infection
and disease. In M. tuberculosis, for example, a recent
study demonstrated that the rate of progression to
active TB depended on the bacterial lineage.26 Other
studies showed M. tuberculosis lineages to be associated
with different clinical manifestations of TB.27,28
Both the recent changes in the human host (i.e. the
emergence of HIV) and in the bacterium (i.e. the
emergence of drug resistance) will influence the
evolutionary trajectory of M. tuberculosis. We urgently
need a better understanding of the genetic diversity
and evolution of M. tuberculosis and the epidemio-
logical and clinical consequences. How does
co-infection affect the genetic population structure
and evolution of M. tuberculosis in sub-Saharan
Africa? What are the clinical and epidemiological
implications of these effects? Does HIV co-infection
influence the frequency and distribution of antimicro-
bial resistance-conferring mutations in M. tuberculosis?
Do the clinical correlates of M. tuberculosis genetic
diversity and the transmission dynamics of M. tuber-
culosis differ depending on HIV status and degree of
HIV-induced immunodeficiency?
Improved understanding of the complex interactions
between genetically diverse hosts and pathogens in
changing environments will require new multidisci-
plinary approaches. In particular, the integration of
systems biology with population sciences and ecology,
in what might be described as ‘systems epidemiology’
is promising (Figure 1).29 This involves combining
genomic and evolutionary analyses of the host and
the pathogen, with immunology, molecular and
clinical epidemiology, and mathematical modelling.
‘Darwinian Medicine’, where evolutionary biology
and biomedicine interact to enhance our understand-
ing of both biological and evolutionary processes, is
part of this concept.30 If successful, such an
integrated approach will inform the development of
new diagnostics, drugs and vaccines, and guide
future public health interventions. Thus, even
though Charles Darwin might not have fully appre-
ciated the significance of infectious microbes at the
time, his legacy will play a crucial role in addressing
challenges such as the dual epidemics of HIV and TB.
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